With the booming development of the medical aesthetics industry, non-surgical medical aesthetic projects are gaining increasing favor from consumers due to their low invasiveness and quick recovery period. In this field, radiofrequency (RF) medical aesthetic products, represented by RF skin therapy devices, have gradually become a market focus due to their significant therapeutic effects and are widely recognized by businesses and consumers.
Recently, Frost & Sullivan (referred to as 'Frost & Sullivan') in collaboration with Weima Qingtong Medical Technology (Wuxi) Co., Ltd. (referred to as 'Weima Medical'), released the 'Blue Book on the Current Development and Future Trends of China's Radiofrequency Medical Beauty Products' at the 8th Ziyalan International Anti-Aging Medical Cosmetology Conference.
Wang Peng, consulting director of Frost & Sullivan's Healthcare Business Unit in Greater China, stated at the release ceremony that the radiofrequency (RF) medical aesthetics industry chain starts with upstream device suppliers, passes through midstream medical aesthetics institutions, and ultimately reaches consumers through downstream customer acquisition platforms. In recent years, with the increase in RF medical aesthetics product categories and market development, relevant policies have been continuously improved, and the regulatory system has become increasingly robust, promoting standardized market operations. Driven by factors such as growing market demand, enhanced consumer awareness, technological innovation, as well as informatization and digitization, the RF medical aesthetics product market is expected to achieve long-term stable growth. In the future, RF medical aesthetics products are expected to further develop to better meet consumers' pursuit of beauty and personalized needs.
Wang Peng, Consulting Director of Healthcare Business Unit, Frost & Sullivan Greater China
The release of the 'Blue Book on the Current Development Status and Future Trends of China's Radiofrequency Medical Beauty Products Industry' will further assist the public in understanding this booming sector. At the same time, the English version of the 'Blue Book on the Current Development Status and Future Trends of China's Radiofrequency Medical Beauty Products Industry' has also been published simultaneously on Frost & Sullivan's global official website, helping outstanding Chinese radiofrequency medical beauty product enterprises enter the global market and build global brand influence.
This 'Blue Book on the Current Development Status and Future Trends of China's RF Medical Beauty Products Industry' focuses on the application of RF technology in the medical beauty field. Taking this as a starting point, it conducts an in-depth analysis of the RF medical beauty product industry chain and favorable policies. It tracks the technological development context of the industry and future trends, explores the huge potential for industry development, and analyzes the driving factors behind market development.
PART.
01
Definition and Classification of Radiofrequency Medical Beauty Products
Radiofrequency (RF) medical aesthetics is a type of medical beauty service based on RF treatment technology, falling under the category of non-surgical energy-based medical aesthetics. RF medical aesthetic products generate thermal effects through the interaction between electromagnetic waves and biological tissues, promoting collagen contraction and regeneration or triggering fat cell metabolism. They are used for skin tightening, reducing wrinkles, or non-invasive fat reduction and shaping. According to electrode configuration, operating mode, and treatment site (such as the dermis or subcutaneous fat layer), RF medical aesthetic products can be classified in multiple dimensions.
According to electrode configuration and current path, radiofrequency medical aesthetic products can be divided into monopolar RF, bipolar RF, multipolar RF, and RF microneedles.
Source: Public information, analysis by Frost & Sullivan
PART.
02
Analysis of the Radiofrequency Medical Beauty Product Industry Chain
In the field of radiofrequency (RF) medical aesthetics products, its complete industrial chain is tightly linked by three core segments: upstream suppliers, midstream medical aesthetics institutions, downstream medical aesthetics customer acquisition platforms, and end consumers.
Source: Public information, analysis by Frost & Sullivan
PART.
03
Investment and financing of radio frequency-based medical beauty enterprises
Currently, global RF-based medical aesthetics companies are active in investment and financing, especially against the backdrop of rapid expansion in the energy source-based medical aesthetics equipment market. North America, Europe, and Asia-Pacific regions have become major competitive areas. Among them, Chinese company Weimai Medical has emerged with a head start due to technological breakthroughs and domestic substitution advantages. Its core product, the high-energy monopolar skin radiofrequency instrument, has passed the Class III medical device certification of China's NMPA and the US FDA, and has completed multiple rounds of financing, attracting investment from industrial capital such as Dihui Bafu and the Beitate Group, as well as state-owned funds.
With the continuous advancement of products from outstanding companies in the radiofrequency medical aesthetics field, the further disclosure of clinical trial data, as well as the subsequent launch and commercialization of products, are expected to further attract capital investment and bring about sustained prosperity and development of the industry.
PART.
04
Market scale of radiofrequency medical beauty products and equipment at Chinese cinema chains
The market scale of radiofrequency (RF) medical beauty products and equipment at Chinese cinema chains has shown rapid growth, increasing from 940 million RMB in 2020 to 4.18 billion RMB in 2024, and is expected to reach 9.05 billion RMB by 2030. This significant growth is mainly driven by several factors: Firstly, the continuous growth in consumer demand for anti-aging and skin tightening treatments has made RF technology popular due to its non-invasive, safe, reliable, and effective characteristics; secondly, the increasing number of products approved by regulatory authorities has provided the market with more high-quality options; in addition, the application scope of RF medical beauty products is also expanding continuously, extending from traditional facial tightening to eye care, body shaping, and other areas, meeting consumers' increasingly diverse beauty needs.
Source: Public information, analysis by Frost & Sullivan
About Weimai Medical
Weimaiqingtong Medical Technology (Wuxi) Co., Ltd. was established in July 2021. It is the first medical device company in China to focus on energy ablation therapy systems as its core technology and provide comprehensive minimally invasive and non-invasive energy medicine solutions. The company adheres to the R&D path of 'integration of medicine and engineering', constructs a competitive advantage through full-process independent research and development, design, and manufacturing, strengthens market exploration, pays attention to brand building, and is committed to becoming a leader in China's energy medicine field, providing high-quality medical devices for more patients.
About Frost & Sullivan's Healthcare Practice
The Frost & Sullivan Healthcare Business Unit has professional analytical capabilities and rich project experience in the healthcare field. Leveraging the global think tank resources of Frost & Sullivan and its cross-industry business development platform in Greater China, the Healthcare Business Unit has unique core advantages in investment and financing services for the life and health industry. The Healthcare Business Unit has a wide range of corporate clients in China and has established a vast customer network over the past 27 years, accumulating extensive project experience in various sub-sectors of life sciences.
Project types include Knowledge Center Services (in-depth content promotion, brand event promotion), Internationalization Strategy Services (going global strategy, industry assessment, global brand promotion, value assessment of go-global pipelines), Pre-IPO Services (DCF valuation, business plan services), IPO listing services (industry advisory, clinical audit, fundraising and investment writing), market research and strategic consulting, etc. It also collaborates with well-known domestic and international information platforms and investment and financing institutions, providing one-stop solutions for enterprises in specialized fields of life sciences, which has attracted widespread attention from investors.
